InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,916.27
(
1.00%
)
Post# of 381635
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgie18

Send PM Follow Ignore
Followers 2114
Posts 90979
Boards Moderated 0
Alias Born 12/17/2011

georgie18

Member Level

Re: None

Monday, 05/06/2024 8:33:43 AM

Monday, May 06, 2024 8:33:43 AM

Post# of 381635
GOSS...7499... 🥳...May 6 (Reuters) - Gossamer Bio said on Monday it will collaborate with Chiesi Group to develop and commercialize its drug seralutinib in multiple indications related to blood pressure conditions.Gossamer is to receive $160 million development reimbursement payment and is eligible to receive up to $146 million in regulatory and $180 million in sales milestones as part of the deal. (Reporting by Christy Santhosh; Editing by Vijay Kishore)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up